Breaking News Instant updates and real-time market news.

AAPL

Apple

$116.30

0.25 (0.22%)

, FB

Facebook

$128.88

-1.36 (-1.04%)

08:55
10/12/16
10/12
08:55
10/12/16
08:55

Notable open interest changes for October 12th

Tuesday's total option volume of 16.7 million contracts resulted in net open interest growth of 2.41 million calls and 2.28 million puts. Apple (AAPL), Facebook (FB), Bank of America (BAC) and Chesapeake Energy (CHK) saw the greatest growth. Top five new positions opened include 24k Chesapeake Energy (CHK) Oct-16 6.5 calls, 18k Coca Cola (KO) Dec-16 40 puts, 15k JPMorgan Chase (JPM) Dec-16 65 puts, 15k Symantec (SYMC) Jan-18 31 calls and 14k Altria Group (MO) Dec-16 62.5 calls.

AAPL

Apple

$116.30

0.25 (0.22%)

FB

Facebook

$128.88

-1.36 (-1.04%)

BAC

Bank of America

$16.11

-0.19 (-1.17%)

CHK

Chesapeake

$6.28

-0.16 (-2.48%)

  • 23

    Oct

  • 25

    Oct

  • 02

    Nov

  • 14

    Nov

AAPL Apple
$116.30

0.25 (0.22%)

10/11/16
DRXL
10/11/16
NO CHANGE
Target $185
DRXL
Buy
Apple could gain 8M iPhone units from Note 7 troubles, says Drexel Hamilton
Drexel Hamilton analyst Brian White estimates Apple (AAPL) has an opportunity to pick up "at least" 8 million incremental iPhone units in calendar year 2016 due to the Galaxy Note 7 being scrapped, noting that original market expectations were for Samsung (SSNLF) to ship about 10M-14M Galaxy Note 7 units in the second half of this year. The "fiasco" could permanently damage Samsung's smartphone brand, resulting in Apple market share gains, White added. The analyst keeps a Buy rating and $185 price target on Apple shares.
10/12/16
WELS
10/12/16
NO CHANGE
WELS
Market Perform
Wells doesn't see Apple as biggest beneficiary from Samsung issues
Wells Fargo analyst Maynard Um attributes the recent rally in shares of Apple (AAPL), at least in part, to Samsung's (SSNLF) issues with its Note 7 phones. Apple gained an incremental $14B in market capitalization at its intraday peak, which the analyst believes embeds more than 3M of incremental iPhone 7 Plus units. Samsung's production halt will help Apple, but other Android vendors with 5.7 inch phones could see a bigger benefit if Android users prefer to stick with Android, Um tells investors in a research note. He points out that LG, Kyocera, and Microsoft (MFST) have 5.7 inch Android phones at U.S. carriers. Um thinks expectations for Apple into earnings "have risen materially." He keeps a Market Perform rating on the iPhone maker. Apple closed yesterday up 25c to $116.30.
10/12/16
GSCO
10/12/16
NO CHANGE
Target $124
GSCO
Buy
Goldman expects a beat and raise quarter for Apple
Goldman analyst Simona Jankowski expects Apple to report a solid beat-and raise quarter on the back of iPhone 7 strength. The analyst said iPhone 7 demand is tracking ahead of expectations driven by the one week earlier than expected launch, better than expected carrier promotions, and Samsung Note 7 issues. Jankowski raised his September quarter iPhone unit estimate by 1M units to 45.6M, versus consensus of 44.5M, and raised the December quarter unit estimate by 2M to 78.1M, versus consensus of 75.5M. The analyst rates Apple a Buy with a $124 price target on share.
10/12/16
OTRG
10/12/16
UPGRADE
OTRG
Positive
Apple upgraded to Positive from Negative at OTR Global
FB Facebook
$128.88

-1.36 (-1.04%)

10/11/16
NEED
10/11/16
NO CHANGE
Target $150
NEED
Buy
Needham raising Facebook estimates ahead of results
Needham analyst Laura Martin is raising her Facebook estimates for Q3 as she increases her estimates for Ad revenue going forward based on the company's increased number of advertisers using its platform, and her belief that ad growth will continue to realize robust performance for at least the next 12 to 18 months. The analyst reiterates a Buy rating and $150 price target on the shares.
10/03/16
BOFA
10/03/16
NO CHANGE
Target $150
BOFA
Buy
BofA/Merrill remains positive on Facebook heading into Q3 report
BofA/Merrill remains positive on Facebook heading into the Q3 report based on strong engagement, pricing tailwinds, and advertiser growth. The firm's analyst rate shares a Buy with a $150 price target and sees potential for a Q3 beat.
10/04/16
PIPR
10/04/16
NO CHANGE
Target $185
PIPR
Overweight
Facebook issues at Marketplace launch a 'non-event,' says Piper Jaffray
Piper Jaffray analyst Gene Munster noted that after Facebook launched its new Marketplace offering on Monday that some users listed prohibited items, such as guns and drugs, that were not caught as they should have been by the company's filter. However, he views the misstep at launch as a "non-event" and thinks nothing has changed in term of Facebook's ability to build world-class products and go after new markets. Munster keeps an Overweight rating and $185 price target on Facebook shares.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Alphabet, Facebook can meet Street estimates, says Wells Fargo
Wells Fargo says that investors are concerned about the ability of Facebook (FB) and Google (GOOG,GOOGL) to meet Street estimates because forecasts continue to indicate that TV's ad share will be relatively stable over the next two years. But Wells says that Facebook and Google will continue to gain share from "non-TV media" and could see increased revenue from "non-advertising marketing services" such as sponsorships and public relations. Wells keeps Outperform ratings on both stocks.
BAC Bank of America
$16.11

-0.19 (-1.17%)

10/11/16
COMP
10/11/16
INITIATION
Target $13
COMP
Neutral
Bank of America initiated with a Neutral at Compass Point
Compass Point analyst Charles Peabody initiated Bank of America with a Neutral and a $13 price target.
10/10/16
OPCO
10/10/16
NO CHANGE
OPCO
Oppenheimer technical analyst upgrades Financials, downgrades Consumer Staples
Oppenheimer technical analyst Ari Wald upgraded the Financials sector to Market Weight and downgraded Consumer Staples to Underweight in next step in the firm's "cyclical rotation road map." Wald identified Ameriprise (AMP), Bank of America (BAC), Citi (C), Goldman Sachs (GS), Lincoln National (LNC) and SunTrust (STI) as six stocks breaking higher that he sees as likely to benefit from internal market rotation.
09/16/16
GSCO
09/16/16
NO CHANGE
Target $19
GSCO
Conviction Sell
Bank of America operating leverage hitting an inflection, says Goldman
Goldman analyst Richard Ramsden believes Bank of America is hitting an inflection point in operating leverage driven by low single digit growth, stable credit, and absolute reductions in the expense base. The analyst believes topline growth will reach approximately 4% annually through to 2018, driven by consumer bank and wealth management initiatives. Ramsden reiterates his Conviction Buy rating on Bank of American and raised his price target to $19 from $17 given the combination of revenue growth and expense discipline.
09/13/16
SOCG
09/13/16
DOWNGRADE
Target $42
SOCG
Sell
Societe Generale cuts Citi to Sell, Bank of America to Hold
Societe Generale downgraded Citi (C) to Sell from Hold and Bank of America (BAC) to Hold from Buy. The firm has a $42 price target for shares of Citi and attributes an increased negative stance on Cards for the downgrade. Societe Generale has a $17 price target for Bank of America and cites revenue growth for the downgrade to Hold. Citi is trading down 86c to $46.93 and Bank of America is trading down 19c to $15.71.
CHK Chesapeake
$6.28

-0.16 (-2.48%)

08/16/16
08/16/16
UPGRADE

On The Fly: Top analyst upgrades
Catch up on today's top analyst upgrades with this list compiled by The Fly: 1. Vipshop (VIPS) was upgraded to Buy from Neutral at BofA/Merrill. 2. Chesapeake (CHK) was upgraded to Equalweight from Underweight and Forum Energy (FET) was upgraded to Overweight from Equalweight at Capital One. 3. Noble Corp. (NE) and Patterson-UTI (PTEN) were upgraded to Neutral from Underperform while Marathon Oil (MRO) and Sasol (SSL) were upgraded to Buy from Neutral at BofA/Merrill. 4. Shenandoah (SHEN) was upgraded to Outperform from Market Perform at Raymond James with analyst Ric Prentiss citing valuation, increased visibility into the future of the combined nTelos (NTLS) and Sprint (S) entity, and expectations of further transactions with Sprint that would expand its wireless coverage footprint and serve as a further catalysts for shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/09/16
WDLK
09/09/16
UPGRADE
Target $10
WDLK
Buy
Chesapeake upgraded to Buy from Hold at Wunderlich
Wunderlich analyst Jason Wangler upgraded Chesapeake Energy to Buy saying the company's assets are performing and its balance sheet is improving. The analyst raised his price target for the shares to $10 from $6.
09/09/16
09/09/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chesapeake (CHK) upgraded to Buy from Hold at Wunderlich with analyst Jason Wangler saying the company's assets are performing and its balance sheet is improving. 2. GameStop (GME) upgraded to Buy from Neutral at Hilliard Lyons. 3. Finisar (FNSR) upgraded to Buy from Neutral at MKM Partners with analyst Michael Genovese saying he is "extremely upbeat on the Optical components/module industry," and Chinese demand for 10G and 100G Optical modules appears it can stay strong for multiple years. 4. Randgold (GOLD) upgraded to Buy from Neutral at UBS with the firm citing the recent pullback in the shares and the potential for a dividend raise in 2017. 5. Teekay LNG (TGP) upgraded to Outperform from Market Perform at Wells Fargo analyst Michael Webber saying the discount to net asset value and the company's progress around financing its order book make the valuation "particularly compelling." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/16
FBRC
09/13/16
INITIATION
Target $5
FBRC
Underperform
Chesapeake initiated with an Underperform at FBR Capital
FBR Capital analyst Joseph Allman started Chesapeake Energy with an Underperform rating and $5 price target. The company's "debt and transportation commitments hole still appears too deep to dig out of," Allman tells investors in a research note. He views Chesapeake's equity as "significantly overvalued" and thinks the company's financial condition "will continue to be stressed."

TODAY'S FREE FLY STORIES

AZRX

AzurRx BioPharma

$3.51

-0.04 (-1.13%)

15:54
04/28/17
04/28
15:54
04/28/17
15:54
Hot Stocks
Breaking Hot Stocks news story on AzurRx BioPharma »

Matthew Balk reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMF

OneMain Holdings

$23.36

-1.26 (-5.12%)

15:51
04/28/17
04/28
15:51
04/28/17
15:51
Options
Opening action in OneMain Holdings puts as shares drop »

Opening action in OneMain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 25

    May

CHFC

Chemical Financial

$47.97

-0.79 (-1.62%)

15:50
04/28/17
04/28
15:50
04/28/17
15:50
Upgrade
Chemical Financial rating change  »

Chemical Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

BOFI

BofI Holding

$24.76

0.52 (2.15%)

15:46
04/28/17
04/28
15:46
04/28/17
15:46
Options
BofI Holding call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 30

    May

B

Barnes Group

$55.35

2.1 (3.94%)

15:43
04/28/17
04/28
15:43
04/28/17
15:43
Downgrade
Barnes Group rating change  »

Barnes Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

ADI

Analog Devices

$77.85

-0.13 (-0.17%)

15:36
04/28/17
04/28
15:36
04/28/17
15:36
Options
Analog Devices put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

MDXG

MiMedx

$11.40

0.3 (2.70%)

15:32
04/28/17
04/28
15:32
04/28/17
15:32
Recommendations
MiMedx analyst commentary  »

MiMedx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 06

    Jun

GST

Gastar Exploration

$1.31

0.01 (0.77%)

15:30
04/28/17
04/28
15:30
04/28/17
15:30
Conference/Events
Gastar Exploration to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 05

    May

CLVS

Clovis

$58.21

-0.43 (-0.73%)

15:26
04/28/17
04/28
15:26
04/28/17
15:26
Options
Clovis call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

$NSD

NASDAQ Market Internals

15:17
04/28/17
04/28
15:17
04/28/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIG

Fortress

$8.04

0.005 (0.06%)

, SFTBF

SoftBank

$75.60

0.71 (0.95%)

15:17
04/28/17
04/28
15:17
04/28/17
15:17
Periodicals
Fortress exploring sale of Logan Circle bond fund unit, Reuters says »

Fortress Investment Group…

FIG

Fortress

$8.04

0.005 (0.06%)

SFTBF

SoftBank

$75.60

0.71 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
04/28/17
04/28
15:16
04/28/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
04/28/17
04/28
15:15
04/28/17
15:15
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

CAG

Conagra Brands

$38.82

0.005 (0.01%)

15:11
04/28/17
04/28
15:11
04/28/17
15:11
Options
Downside put buyer in Conagra Foods »

Downside put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAH

Cardinal Health

$72.36

-0.78 (-1.07%)

15:10
04/28/17
04/28
15:10
04/28/17
15:10
Initiation
Cardinal Health initiated  »

Cardinal Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

FIG

Fortress

$8.04

0.01 (0.12%)

15:04
04/28/17
04/28
15:04
04/28/17
15:04
Periodicals
Breaking Periodicals news story on Fortress »

Fortress exploring sale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$9.06

0.03 (0.33%)

15:01
04/28/17
04/28
15:01
04/28/17
15:01
Options
Sprint calls active ahead of earnings next week »

Sprint calls active ahead…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

GME

GameStop

$22.80

-0.3 (-1.30%)

14:56
04/28/17
04/28
14:56
04/28/17
14:56
Options
GameStop put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 31

    May

BSX

Boston Scientific

$26.43

0.25 (0.95%)

14:55
04/28/17
04/28
14:55
04/28/17
14:55
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 07

    Jun

  • 27

    Jun

TKPYY

Takeda Pharmaceutical Co. Ltd.

$23.98

0.05 (0.21%)

14:51
04/28/17
04/28
14:51
04/28/17
14:51
Hot Stocks
FDA grants accelerated approval to Takeda's brigatinib »

On April 28, 2017, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$39.76

-0.34 (-0.85%)

14:48
04/28/17
04/28
14:48
04/28/17
14:48
Conference/Events
The Progressive Corporation to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVO

Cenveo

$4.39

0.095 (2.21%)

14:48
04/28/17
04/28
14:48
04/28/17
14:48
Hot Stocks
Breaking Hot Stocks news story on Cenveo »

Nathu Ram Puri reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

BMY

Bristol-Myers

$56.01

0.34 (0.61%)

14:42
04/28/17
04/28
14:42
04/28/17
14:42
Hot Stocks
Bristol-Myers announces European Commission approval of Opdivo »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 06

    Jun

TAP

Molson Coors

$95.84

0.06 (0.06%)

14:41
04/28/17
04/28
14:41
04/28/17
14:41
Conference/Events
Molson Coors to hold an earnings follow-up conference call »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

IWM

iShares Trust Russell 2000 Index Fund

$139.37

-1.58 (-1.12%)

, RUT

Russell 2000 Index

14:40
04/28/17
04/28
14:40
04/28/17
14:40
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT)…

IWM

iShares Trust Russell 2000 Index Fund

$139.37

-1.58 (-1.12%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.